Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

BACKGROUND: The cardiovascular effect of liraglutide, a glucagon-like peptide 1 analogue, when added to standard care in patients with type 2 diabetes, remains unknown. METHODS: In this double-blind trial, we randomly assigned patients with type 2 diabetes and high cardiovascular risk to receive lir...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:N Engl J Med
Main Authors: Marso, Steven P., Daniels, Gilbert H., Brown-Frandsen, Kirstine, Kristensen, Peter, Mann, Johannes F.E., Nauck, Michael A., Nissen, Steven E., Pocock, Stuart, Poulter, Neil R., Ravn, Lasse S., Steinberg, William M., Stockner, Mette, Zinman, Bernard, Bergenstal, Richard M., Buse, John B.
Format: Artigo
Sprog:Inglês
Udgivet: 2016
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4985288/
https://ncbi.nlm.nih.gov/pubmed/27295427
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1603827
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker